Developing and manufacturing testosterone drug products requires more than standard pharmaceutical manufacturing capabilities. As a Schedule III controlled substance in the US (Schedule IV in Canada), testosterone presents unique regulatory, technical, operational, and packaging challenges that demand specialized infrastructure and experienced personnel. Companies without established expertise can encounter unnecessary development delays, formulation issues, regulatory hurdles, , and commercialization risks.
CPL provides end-to-end testosterone manufacturing services, supporting pharmaceutical companies from early formulation development and clinical manufacturing through validation, packaging, and commercial production. By bringing every stage of development under a single, experienced organization, CPL helps reduce technical risk while creating a more efficient path to commercialization.
Testosterone Manufacturing Begins with Specialized Infrastructure
Manufacturing testosterone products requires capabilities that extend well beyond conventional topical or liquid pharmaceutical production.
The process begins before manufacturing even starts. Testosterone as an active pharmaceutical ingredient (API) requires secure storage, controlled access, and documented inventory management throughout the supply chain. Every gram of material must be tracked, stored, and handled according to strict regulatory requirements.
Inside the manufacturing facility, preventing cross-contamination is equally important. Dedicated manufacturing suites with appropriate air handling systems, specialized equipment, and controlled workflows help ensure testosterone products remain isolated from other pharmaceutical products being manufactured within the facility.
Because many testosterone formulations contain high concentrations of alcohol, manufacturing environments must also incorporate explosion-proof equipment designed to safely process flammable solvents. These facility requirements represent a significant investment that many contract manufacturers simply do not possess.
Beyond manufacturing infrastructure, companies must also maintain the permits and controlled substance procedures necessary to import testosterone API, export finished drug products, and comply with government reporting requirements. These operational requirements add another layer of complexity that experienced manufacturing partners like CPL are equipped to manage.
Technical Expertise Extends Beyond Manufacturing
Testosterone is a complex molecule that introduces formulation and analytical challenges throughout development.
Its limited solubility requires specialized formulation expertise to achieve complete dissolution while preventing crystallization over the product’s shelf life. Selecting the appropriate solvent system and optimizing formulation parameters are essential to maintaining product stability and performance.
Analytical testing presents another layer of complexity. Testosterone products require validated methods capable of monitoring impurities, and product quality throughout development and commercial manufacturing. Furthermore, handling of some of the impurities requires special permits as they are controlled substances as well. Experience with these analytical and regulatory requirements helps reduce development risk while supporting regulatory submissions.
These technical considerations are often the difference between a smooth development program and one that experiences costly reformulation or regulatory delays.
Packaging Plays a Critical Role in Product Performance
Packaging testosterone products requires far more than simply filling containers.
Many commercial testosterone products utilize metered-dose pumps that must consistently deliver the correct amount of medication with every actuation. Filling these systems requires specialized equipment and validated manufacturing processes that eliminate air pockets while maintaining dosing accuracy.
Sachet packaging introduces another technical consideration. Certain formulation components, including permeation enhancers that improve drug absorption through the skin, can interact with packaging materials over time. Without understanding these interactions, the amount of active in the formulation reaching the target site in the patient may decrease during storage.
CPL’s experience manufacturing testosterone products has provided valuable insight into these formulation and packaging interactions, allowing development teams to account for these variables early and maintain consistent product performance throughout the product’s shelf life.
Experience Solves Problems Before They Reach Patients
Experience is most valuable when unexpected technical challenges arise.
While supporting the development of a testosterone product, CPL worked with a pharmaceutical company that encountered a gradual reduction in the effectiveness of a key permeation enhancer during long-term stability studies. Initial testing suggested the formulation met specifications, but further investigation revealed that a portion of the permeation enhancer was binding to the sachet packaging material over time.
Rather than treating the issue as a manufacturing failure, CPL conducted targeted studies to quantify the interaction between the formulation and the packaging system. Using those findings, the team optimized the formulation to ensure patients continued receiving the intended therapeutic dose throughout the product’s shelf life.
The revised product successfully progressed through regulatory approval, process validation, and commercialization.
This type of technical problem-solving reflects the value of working with CPL that has decades of testosterone manufacturing experience. Many formulation and packaging challenges can only be solved by our teams that have encountered them before.
End-to-End Testosterone Manufacturing Services
CPL supports pharmaceutical companies throughout the entire product lifecycle.
Services begin with formulation development, where development scientists work alongside customers to optimize formulations for clinical studies and future commercial manufacturing. Projects then progress through scale-up, validation, commercial production, and packaging.
CPL supports a broad range of testosterone dosage forms, including topical gels and solutions. Packaging capabilities include tubes, sachets, metered-dose pumps, giving pharmaceutical companies flexibility as products evolve throughout their lifecycle.
For companies developing generic testosterone products, CPL also provides in-house In Vitro Release Testing (IVRT) services to support formulation development and demonstrate comparable release characteristics.
By integrating development, analytical testing, manufacturing, packaging, and quality systems under one organization, CPL helps minimize technology transfer challenges, improve communication, and reduce project timelines.
Regulatory Experience Simplifies a Complex Process
Testosterone manufacturing involves regulatory responsibilities that extend beyond traditional pharmaceutical production.
Importing testosterone APIs and impurities, exporting finished drug products, maintaining controlled substance permits, and complying with government reporting requirements all require established systems and experienced, dedicated personnel.
CPL has spent decades developing these capabilities. Established quality systems, a trained Qualified Person in Charge (QPIC) to handle any testosterone related material, secure storage procedures, controlled substance documentation, and permit management help customers navigate regulatory requirements efficiently while maintaining compliance throughout the supply chain.
This operational experience becomes particularly valuable for products moving across international borders, where properly managed permits and documentation help prevent unnecessary delays.
Choosing the Right Testosterone CDMO
Selecting a testosterone manufacturing partner requires more than evaluating production capacity.
Pharmaceutical companies should look for a CDMO partner with demonstrated hormone manufacturing experience, dedicated containment capabilities, explosion-proof manufacturing equipment, controlled substance infrastructure, specialized analytical expertise, and packaging experience specific to testosterone dosage forms.
Equally important is selecting a partner that communicates proactively throughout development and commercialization. Testosterone programs often require coordination across formulation development, manufacturing, analytical testing, packaging, quality assurance, permitting, and logistics. Maintaining clear communication throughout each phase helps identify potential issues early and keeps projects moving forward.
These capabilities are developed through years of successfully manufacturing testosterone products, not by treating hormone manufacturing as an extension of standard topical production.
Partner with CPL for Testosterone Manufacturing Services
Testosterone manufacturing is not the place to experiment. The combination of controlled substance regulations, specialized manufacturing infrastructure, formulation complexity, packaging considerations, and regulatory requirements demands a partner with proven experience.
CPL brings decades of expertise in testosterone formulation development, manufacturing, analytical testing, packaging, and commercialization. From early product concepts and clinical development through commercial supply, CPL provides the technical knowledge, operational infrastructure, and collaborative project management needed to help pharmaceutical companies reduce risk and accelerate development.
Schedule a meeting with CPL to discuss your testosterone development or manufacturing program and learn how an experienced partner can help move your product from concept to commercial success.